(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 67% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.33%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.78%.
Dbv Technologies Sa's revenue in 2025 is $3,801,000.On average, 1 Wall Street analysts forecast DBVT's revenue for 2025 to be $719,111,909, with the lowest DBVT revenue forecast at $719,111,909, and the highest DBVT revenue forecast at $719,111,909. On average, 1 Wall Street analysts forecast DBVT's revenue for 2026 to be $791,707,969, with the lowest DBVT revenue forecast at $791,707,969, and the highest DBVT revenue forecast at $791,707,969.
In 2027, DBVT is forecast to generate $2,736,734,466 in revenue, with the lowest revenue forecast at $2,736,734,466 and the highest revenue forecast at $2,736,734,466.